Biomedical Engineering Reference
In-Depth Information
prevents memory loss in an animal model of
Alzheimer's disease. Nature 408:982-985
76. Callaway E (2012) Alzheimer's drugs take a
new tack. Nature 489:13-14
77. Games D, Adams D, Alessandrini R et al
(1995) Alzheimer-type neuropathology in
transgenic mice overexpressing V717F beta-
amyloid
ing in aged amyloid precursor protein trans-
genic mice. Nat Neurosci 2:271-276
89. Selkoe DJ (2002) Alzheimer's disease is a syn-
aptic failure. Science 298:789-791
90. Terry RD, Masliah E, Salmon DP et al (1991)
Physical basis of cognitive alterations in
Alzheimer's disease: synapse loss is the major
correlate of cognitive impairment. Ann
Neurol 30:572-580
91. Galvan V, Bredesen DE (2007) Neurogenesis
in the adult brain: implications for Alzheimer's
disease. CNS Neurol Disord Drug Targets
6:303-310
92. Abdipranoto A, Wu S, Stayte S et al (2008)
The role of neurogenesis in neurodegenera-
tive diseases and its implications for therapeu-
tic development. CNS Neurol Disord Drug
Targets 7:187-210
93. Biscaro B, Lindvall O, Hock C et al (2009)
Abeta immunotherapy protects morphology
and survival of adult-born neurons in doubly
transgenic APP/PS1 mice. J Neurosci
29:14108-14119
94. Kiyota T, Okuyama S, Swan RJ et al (2010)
CNS expression of anti-infl ammatory cyto-
kine interleukin-4 attenuates Alzheimer's
disease-like pathogenesis in APP + PS1 big-
enic mice. FASEB J 24:3093-3102
95. Hefti F (1986) Nerve growth factor promotes
survival of septal cholinergic neurons after fi m-
brial transections. J Neurosci 6:2155-2162
96. Bishop KM, Hofer EK, Mehta A et al (2008)
Therapeutic potential of CERE-110 (AAV2-
NGF): targeted, stable, and sustained NGF
delivery and trophic activity on rodent basal
forebrain cholinergic neurons. Exp Neurol
211:574-584
97. Arvanitakis ZPS, Bartus RT, Bennett D
(2007) A phase I clinical trial of CERE-110
(AAV-NGF) gene delivery in Alzheimer's dis-
ease. American Academy of Neurology
Annual Meeting, Boston, MA
98. Rafi i MS, Baumann TL, Bakay RA et al
(2014) A phase1 study of stereotactic gene
delivery of AAV2-NGF for Alzheimer's dis-
ease. Alzheimer's Dement 10(5):571-581
99. Nagahara AH, Merrill DA, Coppola G et al
(2009) Neuroprotective effects of brain-
derived neurotrophic factor in rodent and pri-
mate models of Alzheimer's disease. Nat Med
15:331-337
100. Mudo G, Bonomo A, Di Liberto V et al
(2009) The FGF-2/FGFRs neurotrophic sys-
tem promotes neurogenesis in the adult brain.
J Neural Transm 116:995-1005
101. Kuhn HG, Winkler J, Kempermann G et al
(1997) Epidermal growth factor and fi bro-
precursor
protein.
Nature
373:523-527
78. Hsiao K, Chapman P, Nilsen S et al (1996)
Correlative memory defi cits, Abeta elevation,
and amyloid plaques in transgenic mice.
Science 274:99-102
79. Yoshiyama Y, Higuchi M, Zhang B et al
(2007) Synapse loss and microglial activation
precede tangles in a P301S tauopathy mouse
model. Neuron 53:337-351
80. de Calignon A, Polydoro M, Suarez-Calvet M
et al (2012) Propagation of tau pathology in
a model of early Alzheimer's disease. Neuron
73:685-697
81. Grueninger F, Bohrmann B, Czech C et al
(2010) Phosphorylation of Tau at S422 is
enhanced by Abeta in TauPS2APP triple
transgenic mice. Neurobiol Dis 37:294-306
82. West MJ, Gundersen HJ (1990) Unbiased
stereological estimation of the number of
neurons in the human hippocampus. J Comp
Neurol 296:1-22
83. Sze CI, Troncoso JC, Kawas C et al (1997)
Loss of the presynaptic vesicle protein synap-
tophysin in hippocampus correlates with cog-
nitive decline in Alzheimer disease. J
Neuropathol Exp Neurol 56:933-944
84. Arendash GW, King DL, Gordon MN et al
(2001) Progressive, age-related behavioral
impairments in transgenic mice carrying both
mutant amyloid precursor protein and prese-
nilin-1 transgenes. Brain Res 891:42-53
85. Kiyota T, Yamamoto M, Schroder B et al
(2009) AAV1/2-mediated CNS gene deliv-
ery of dominant-negative CCL2 mutant sup-
presses gliosis, beta-amyloidosis, and learning
impairment of APP/PS1 mice. Mol Ther
17:803-809
86. Kiyota T, Ingraham KL, Swan RJ et al (2012)
AAV serotype 2/1-mediated gene delivery of
anti-infl ammatory interleukin-10 enhances
neurogenesis and cognitive function in
APP + PS1 mice. Gene Ther 19:724-733
87. Hsia AY, Masliah E, McConlogue L et al
(1999) Plaque-independent disruption of
neural circuits in Alzheimer's disease mouse
models. Proc Natl Acad Sci U S A
96:3228-3233
88. Chapman PF, White GL, Jones MW et al
(1999) Impaired synaptic plasticity and learn-
Search WWH ::
Custom Search